| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Nov―22 |
Body Volatilome Study Strategy for COVID-19 Biomarker Identification Considering Exogenous Parameters |
Elsa Boudard, Nabil Moumane, José Dugay, Jérôme Vial, Didier Thiébaut |
| 2 |
[GO] |
2023―Jan―23 |
Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication |
Kateřina Veselá, Zora Mělková, Nikita Abramenko, Zdeněk Kejík, Robert Kaplánek, Petr Dytrych, Alla Sinica, Oleksandra Vozniuk, Pavel Martásek, Milan Jakubek |
| 3 |
[GO] |
2022―Oct―12 |
Development and Validation of HPLC-DAD Method for the Determination of Favirapir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favirapir |
Mohammad Hailat, Israa Al-Ani, Zainab Zakareia, Ramadan Al-Shdefat, Osaid Al-Meanazel, Md. Khalid Anwer, Mohammed Hamad, Walid Abu Rayyan, Riad Awad, Wael Abu Dayyih |
| 4 |
[GO] |
2021―Oct―18 |
Separation and Disinfection of Contagious Aerosols from the Perspective of SARS-CoV-2 |
J. J. H. Brouwers |
|
